Galectin Therapeutics【GALT】株式ニュース

名称	銘柄コード	市場	種別
Galectin Therapeutics Inc	GALT	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.05	-1.89%	2.60	05:25:00

始値	安値	高値	終値	前日終値
2.63	2.50	2.71	2.60	2.65

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/15	20:55	EDGAR2	Form 8-K - Current report
2024/5/15	20:50	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/3/05	02:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/17	01:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/02	22:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/18	22:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	06:15	EDGAR2	Form 8-K - Current report
2023/12/08	01:42	EDGAR2	Form 8-K - Current report
2023/12/02	06:50	EDGAR2	Form 5 - Annual statement of changes in beneficial ownership..
2023/12/02	06:38	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2023/12/01	22:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/16	07:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/13	23:21	EDGAR2	Form 8-K/A - Current report: [Amend]
2023/11/13	22:45	GLOBE	UPDATE – Galectin Therapeutics Reports Financial Results for..
2023/11/13	22:00	GLOBE	Galectin Therapeutics Reports Financial Results for the..
2023/11/13	21:55	EDGAR2	Form 8-K - Current report
2023/11/13	21:50	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03	21:00	GLOBE	Galectin Therapeutics to Share Five Scientific Presentations..
2023/11/01	05:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/23	21:00	GLOBE	Galectin Therapeutics to Participate in the H.C. Wainwright..
2023/10/16	21:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/12	21:00	GLOBE	Galectin Therapeutics Announces Nomination of Dr. Benjamin..
2023/10/06	21:05	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2023/10/06	21:03	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/10/03	21:00	GLOBE	Galectin Therapeutics Reports the Positive Outcome of the..
2023/10/02	20:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/28	03:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/26	21:00	GLOBE	Galectin Therapeutics to Present Update on its Belapectin..
2023/9/18	22:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/12	05:38	EDGAR2	Form 144 - Report of proposed sale of securities
2023/9/11	21:00	GLOBE	Galectin Therapeutics to Participate in the H.C. Wainwright..
2023/9/08	01:00	GLOBE	Galectin Therapeutics to Present Data on Liver Cirrhosis at..
2023/9/01	20:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/16	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/14	21:00	GLOBE	Galectin Therapeutics Reports Financial Results for the..
2023/8/14	20:55	EDGAR2	Form 8-K - Current report
2023/8/14	20:51	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/01	05:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/20	20:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..